A Phase II Study Evaluating T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine PDS01ADC in Localized High and Intermediate Risk Prostate Cancer Treated With Androgen Deprivation Therapy
Clinical trial NCT05361798 · RECRUITING
Trial details
- NCT number
- NCT05361798
- Sponsor
- National Cancer Institute (NCI)
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-12
- Primary completion
- 2027-08-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.